Angiogenesis and antiangiogenic strategies in pancreatic cancer

Author： Fisher William   Berger David  

Publisher： Humana Press, Inc

ISSN： 1537-3649

Source： International Journal of Gastrointestinal Cancer, Vol.33, Iss.1, 2003-02, pp. : 79-88

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Angiogenic Agents in Pancreatic Cancer: A Review

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 5, 2011-01 ,pp. : 464-469

Bentham Science Publishers

Access to resources Recommend Favorite

EMAP II-Based Antiangiogenic-Antiendothelial In Vivo Combination Therapy of Pancreatic Cancer

By Schwarz Roderich  

Annals of Surgical Oncology, Vol. 17, Iss. 5, 2010-05 ,pp. : 1442-1452

Springer Publishing Company

Access to resources Recommend Favorite

Antiangiogenic strategies, compounds, and early clinical results in breast cancer

By Morabito A.   Sarmiento R.   Bonginelli P.   Gasparini G.  

Critical Reviews in Oncology/Hematology, Vol. 49, Iss. 2, 2004-02 ,pp. : 91-107

Elsevier

Access to resources Recommend Favorite

Nestin as a novel therapeutic target for pancreatic cancer via tumor angiogenesis

By Yamahatsu Kazuya   Matsuda Yoko   Ishiwata Toshiyuki   Uchida Eiji   Naito Zenya  

International Journal of Oncology, Vol. 40, Iss. 5, 2012-05 ,pp. : 1345-1357

Spandidos Publications

Access to resources Recommend Favorite

Optimizing Gene Silencing Strategies for Pancreatic Cancer

By  

Current Cancer Therapy Reviews, Vol. 9, Iss. 2, 2013-05 ,pp. : 117-125

Bentham Science Publishers

Access to resources Recommend Favorite